Literature DB >> 15727880

General synthesis and biological evaluation of alpha-1-C-substituted derivatives of fagomine (2-deoxynojirimycin-alpha-C-glycosides).

Jean-Yves Goujon1, David Gueyrard, Philippe Compain, Olivier R Martin, Kyoko Ikeda, Atsushi Kato, Naoki Asano.   

Abstract

A general synthesis of alpha-1-C-substituted derivatives of fagomine (2-deoxynojirimycin-alpha-C-glycosides) by ring-opening reactions of an aziridine with various heteroatomic nucleophiles, including thiol, amine, alcohol, carboxylate and phosphate, is described. The nine-step reaction sequence proceeded in an overall yield of 14-28% from tri-O-benzyl-D-glucal. Biological evaluation of alpha-1-C-substituted derivatives of fagomine, of the 2-deoxy analog of alpha-homonojirimycin 19 and its 1,N-anhydro derivative 22 as glycosidase inhibitors is reported. The glycosyl phosphate mimetic 15k was found to display no inhibitory activity towards glycogen phosphorylase b and phosphoglucomutase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15727880     DOI: 10.1016/j.bmc.2004.12.043

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Scope and mechanism of intramolecular aziridination of cyclopent-3-enyl-methylamines to 1-azatricyclo[2.2.1.0(2,6)]heptanes with lead tetraacetate.

Authors:  Huayou Hu; Juan A Faraldos; Robert M Coates
Journal:  J Am Chem Soc       Date:  2009-08-26       Impact factor: 15.419

2.  Design and synthesis of mimics of the T7-loop of FtsZ.

Authors:  Nohemy A Sorto; Phillip P Painter; James C Fettinger; Dean J Tantillo; Jared T Shaw
Journal:  Org Lett       Date:  2013-05-30       Impact factor: 6.005

3.  Iminosugar C-glycoside analogues of α-D-GlcNAc-1-phosphate: synthesis and bacterial transglycosylase inhibition.

Authors:  Che-Hsiung Hsu; Mathias Schelwies; Sebastian Enck; Lin-Ya Huang; Shih-Hsien Huang; Yi-Fan Chang; Ting-Jen Rachel Cheng; Wei-Chieh Cheng; Chi-Huey Wong
Journal:  J Org Chem       Date:  2014-08-29       Impact factor: 4.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.